FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2134267722> ?p ?o ?g. }

• W2134267722 abstract "Previous studies have reported conflicting results for the comparative doses of recombinant follicle stimulating hormone (rFSH) and highly purified human menopausal gonadotrophin (hMG-HP) required per cycle of in vitro fertilisation (IVF); the aim of this study was to determine the average total usage of rFSH versus hMG-HP in a 'real-world' setting using routine clinical practice.This retrospective chart review of databases from four European countries investigated gonadotrophin usage, oocyte and embryo yield, and pregnancy outcomes in IVF cycles (± intra-cytoplasmic sperm injection) using rFSH or hMG-HP alone. Included patients met the National Institute for Health and Clinical Excellence (NICE) guideline criteria for IVF and received either rFSH or hMG-HP. Statistical tests were conducted at 5% significance using Chi-square or t-tests.Of 30,630 IVF cycles included in this review, 74% used rFSH and 26% used hMG-HP. A significantly lower drug usage per cycle for rFSH than hMG-HP (2072.53 +/- 76.73 IU vs. 2540.14 +/- 883.08 IU, 22.6% higher for hMG-HP; p < 0.01) was demonstrated. The median starting dose was also significantly lower for rFSH than for hMG-HP (150 IU vs. 225 IU, 50% higher for hMG-HP, p < 0.01). The average oocyte yield per IVF cycle in patients treated with rFSH was significantly greater than with hMG-HP (10.80 +/- 6.02 vs. 9.77 +/- 5.53; p < 0.01), as was the average mature oocyte yield (8.58 +/- 5.27 vs. 7.72 +/- 4.59; p < 0.01). No significant differences were observed in pregnancy outcomes including spontaneous abortion between the two treatments. There was a significantly higher rate of OHSS (all grades) with rFSH (18.92% vs. 14.09%; p < 0.0001). The hospitalisation rate due to OHSS was low but significantly higher in the rFSH group (1.07% of cycles started vs. 0.67% of cycles started with rFSH and hMG-HP, respectively; p = 0.002).Based on these results, IVF treatment cycles with rFSH yield statistically more oocytes (and more mature oocytes), using significantly less IU per cycle, versus hMG-HP. The incidence of all OHSS and hospitalisations due to OHSS was significantly higher in the rFSH cycles compared to the hMG-HP cycles. However, the absolute incidence of hospitalisations due to OHSS was similar to that reported previously. These results suggest that the perceived required dosage with rFSH is currently over-estimated, and the higher unit cost of rFSH may be offset by a lower required dosage compared with hMG-HP." @default.
• W2134267722 created "2016-06-24" @default.
• W2134267722 creator A5000722834 @default.
• W2134267722 creator A5007168038 @default.
• W2134267722 creator A5021353845 @default.
• W2134267722 creator A5027267977 @default.
• W2134267722 creator A5027446164 @default.
• W2134267722 creator A5033226576 @default.
• W2134267722 creator A5070987510 @default.
• W2134267722 date "2010-11-08" @default.
• W2134267722 modified "2023-09-27" @default.
• W2134267722 title "In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: results from a European retrospective observational chart review" @default.
• W2134267722 cites W2004054496 @default.
• W2134267722 cites W2011618500 @default.
• W2134267722 cites W2036224327 @default.
• W2134267722 cites W2060036285 @default.
• W2134267722 cites W2071578323 @default.
• W2134267722 cites W2096924191 @default.
• W2134267722 cites W2106627071 @default.
• W2134267722 cites W2124608202 @default.
• W2134267722 cites W2141529825 @default.
• W2134267722 cites W2155097016 @default.
• W2134267722 cites W2162398784 @default.
• W2134267722 cites W2163291143 @default.
• W2134267722 cites W2164814768 @default.
• W2134267722 cites W2334326715 @default.
• W2134267722 cites W4246462260 @default.
• W2134267722 doi "https://doi.org/10.1186/1477-7827-8-137" @default.
• W2134267722 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2993713" @default.
• W2134267722 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21059191" @default.
• W2134267722 hasPublicationYear "2010" @default.
• W2134267722 type Work @default.
• W2134267722 sameAs 2134267722 @default.
• W2134267722 citedByCount "18" @default.
• W2134267722 countsByYear W21342677222012 @default.
• W2134267722 countsByYear W21342677222013 @default.
• W2134267722 countsByYear W21342677222014 @default.
• W2134267722 countsByYear W21342677222015 @default.
• W2134267722 countsByYear W21342677222018 @default.
• W2134267722 countsByYear W21342677222019 @default.
• W2134267722 countsByYear W21342677222020 @default.
• W2134267722 countsByYear W21342677222021 @default.
• W2134267722 countsByYear W21342677222022 @default.
• W2134267722 crossrefType "journal-article" @default.
• W2134267722 hasAuthorship W2134267722A5000722834 @default.
• W2134267722 hasAuthorship W2134267722A5007168038 @default.
• W2134267722 hasAuthorship W2134267722A5021353845 @default.
• W2134267722 hasAuthorship W2134267722A5027267977 @default.
• W2134267722 hasAuthorship W2134267722A5027446164 @default.
• W2134267722 hasAuthorship W2134267722A5033226576 @default.
• W2134267722 hasAuthorship W2134267722A5070987510 @default.
• W2134267722 hasBestOaLocation W21342677221 @default.
• W2134267722 hasConcept C104950815 @default.
• W2134267722 hasConcept C126322002 @default.
• W2134267722 hasConcept C131872663 @default.
• W2134267722 hasConcept C134651460 @default.
• W2134267722 hasConcept C16685009 @default.
• W2134267722 hasConcept C181199279 @default.
• W2134267722 hasConcept C2777702977 @default.
• W2134267722 hasConcept C2778478619 @default.
• W2134267722 hasConcept C2778575703 @default.
• W2134267722 hasConcept C2778782382 @default.
• W2134267722 hasConcept C2779234561 @default.
• W2134267722 hasConcept C2779279165 @default.
• W2134267722 hasConcept C2781230225 @default.
• W2134267722 hasConcept C2909827854 @default.
• W2134267722 hasConcept C29456083 @default.
• W2134267722 hasConcept C512716672 @default.
• W2134267722 hasConcept C54355233 @default.
• W2134267722 hasConcept C55493867 @default.
• W2134267722 hasConcept C71315377 @default.
• W2134267722 hasConcept C71924100 @default.
• W2134267722 hasConcept C86803240 @default.
• W2134267722 hasConceptScore W2134267722C104950815 @default.
• W2134267722 hasConceptScore W2134267722C126322002 @default.
• W2134267722 hasConceptScore W2134267722C131872663 @default.
• W2134267722 hasConceptScore W2134267722C134651460 @default.
• W2134267722 hasConceptScore W2134267722C16685009 @default.
• W2134267722 hasConceptScore W2134267722C181199279 @default.
• W2134267722 hasConceptScore W2134267722C2777702977 @default.
• W2134267722 hasConceptScore W2134267722C2778478619 @default.
• W2134267722 hasConceptScore W2134267722C2778575703 @default.
• W2134267722 hasConceptScore W2134267722C2778782382 @default.
• W2134267722 hasConceptScore W2134267722C2779234561 @default.
• W2134267722 hasConceptScore W2134267722C2779279165 @default.
• W2134267722 hasConceptScore W2134267722C2781230225 @default.
• W2134267722 hasConceptScore W2134267722C2909827854 @default.
• W2134267722 hasConceptScore W2134267722C29456083 @default.
• W2134267722 hasConceptScore W2134267722C512716672 @default.
• W2134267722 hasConceptScore W2134267722C54355233 @default.
• W2134267722 hasConceptScore W2134267722C55493867 @default.
• W2134267722 hasConceptScore W2134267722C71315377 @default.
• W2134267722 hasConceptScore W2134267722C71924100 @default.
• W2134267722 hasConceptScore W2134267722C86803240 @default.
• W2134267722 hasIssue "1" @default.
• W2134267722 hasLocation W21342677221 @default.
• W2134267722 hasLocation W21342677222 @default.
• W2134267722 hasLocation W21342677223 @default.
• W2134267722 hasLocation W21342677224 @default.
• W2134267722 hasOpenAccess W2134267722 @default.

• next